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Undoubtedly one of the major problems
that continues to bedevil the recognition and
classification of lymphomas is the ability of
pathologists to reliably and reproducibly
identify the component cells. This, in turn,
relates to the fixation and processing artefacts
of the relatively crude methods used in diag-
nostic histopathology. The -wider use of
cytology, plastic-embedded sections and
immunoenzyme labelling methods could do
much to overcome these problems. My major
criticism ofthis book is that it is based almost
entirely on paraffin-processed material and
the author is unable to illustrate the fine cyto-
logical detail necessary for the recognition
and separation ofthe different tumours ofthe
lymphoreticular system. Many of the illustra-
tions sho-w little more than a series of black
blobs of varying diameters and occasionally
of differing shapes, and are so unhelpful that
they might well have been omitted. This book
is intended for "clinical pathologists, ad-
vanced students, as -well as for oncologists,
histologists and researchers concerned -with
the study of malignant and non-malignant,
lymph cells". I very much regret that I cannot,
recommend it, to any of these groups.
D. H. WRIGHT
The Year in Hematology 1978. Eds. R.
SILBER, J. LOBUE, A. S. GORDON (1979).
New York: Plenum Medical Book Com-
pany. 517 pp. £18.58.
A vast amount of information concerning
clinical and experimental haematology has
accumulated in the last few years. This book
is part of a series which aims to reviewr recent
developments in a variety of fields. The sub-
jects discussed in the present volume range
from experimental topics ofgeneral biological
interest to others ofobvious interest to clinical
haematologists.
Myelo- and lympho-proliferative disorders
are analysed extensively from several angles,
with 6 chapters devoted to them. Four chap-
ters deal with experimental or laboratory
studies. The first reviews the effect of anti-
cancer drugs on the haemopoietic progenitor
cells wsNhich can be studied by in vivo or in
vitro colony assays, and discusses the possi-
bility that analysing the cytotoxicity of
chemotherapeutic agents on the basis of their
effect on the different types of the progenitor
cells studied, might provide a, more rational
approaclh to therapy. Another chapter de-
scribes the in vitro growith patterns of marrow
in acute and chronic granulocytic leukaemia
during various stages of the disease, and
analyses their relevance for the understanding
ofthe pathophysiology ofleukaemia. Data on
cell markers, including viral and foetal anti-
gens are analysed, and their possible relevance
if immunotherapeutic attack is considered,
are discussed critically. A comprehensive
review of the association of chromosome
abnormalities wNith acute leukaemias, chronic
myeloid leukaemias and other myelopro-
liferative disease, as wNell as pre-leukaemias
and lymphoproliferative diseases, gives a
detailed account ofthe information available.
Of considerable interest to clinicians will be
the chapters on treatment of Hodgkin's and
non-Hodgkin's lymphoma, wxvith a careful
analysis of the parameters that may decide
the type oftreatment.
Other chapters describe subjects w%hich will
be of interest to specialists, like those dealing
writh alterations on red-cell-membrane lipids,
factors w\hich regulate the egress of cells from
the marrow, mechanisms ofaction ofheparin,
observations on marrow megakaryocytes,
mechanisms of chloramphenicol and thi-
amphenicol toxicity, and haemoglobin
switch.
Finally, 2 conceptual chapters deal w%vith
the putative role ofproposed regulators ofthe
lympholhaemopoietic system: chalones, and
thymosin and other thymic factors.
The 14 chapters have been written by
authors who wNork actively in their respective
subjects and wrho succeed in providing com-
prehensive and authoritative reviews.
N. TESTA
The Handbook of Cancer Immunology.
Volume 5-Immunotherapy. Ed. HAR-
ROLD WATERS. New York: Garland STPM
Press. 478 pp.
This is the fifth in a series ofbooks designed
to reviewv the current status of tumour
immunology, and at first sight is rather a
"mixed bag" of some 17 chapters covering
experimental and clinical immunotherapy.
The main emphasis, however, is the immuno-
logical background of the disease and the
immunological effects of immunotherapeutic
agents and possible therapeutic techniques,
indicating their future potential, rather than50() BOOK REVIEWS
merely a reviewr of the current status of
clinical and experimental trials.
The first chapter review-s lymphocyte and
antibody responses to experimental tumours.
Although antibody-lymphocyte interactions
are covered, the currently fashionable natural
killer cell is surprisingly scantily described in
only one short paragraph. The account in the
second chapter, of the possibility of tumour
localization of antibody directed against
tumour or tumour stroma, follows a his-
torical line, and whether there really is
potential for this approach clinically is un-
clear. The use of cytotoxic drugs coupled to
antibody, and antibody-drug interactions is
briefly mentioned, but not review-ed else-
wNhere in this volume. The third chapter
extensively reviews the cur-rent concept of
the immune mnacrophage, and macrophages
activated by immunotherapeutic agents such
as BCG and C. parvum and their proposed
mechanisms of tumour-cell destruction. Fur-
ther chapters (5 and 6) reviewA the evidence
that such immune potentiators and other
agents, including levamisole, double-stranded
RNA and endotoxin, exert their effects
through changes in cyclic GMP and AMP
levels in macrophages and lymphocytes, and
discusses the potential of such agents for
future therapeutic application. The history
and awide immunological effects of levamisole
are further covered in Chapter 7, together
with its clinical application to a Awide variety
of malignant diseases. The realistic overall
conclusion from these trials, stressed by the
authors, is that they have not yet yielded con-
clusive evidence of benefit, but that further
trials are Awarranted. The clinical application
of levamisole to breast cancer is covered in
greater depth in Chapter 8 wA-here the detailed
results of clinical trials are presented, and the
interpretation is more optimistic. Clhapters
9 and 10 cover the immunotherapy of experi-
mental and human cancer Awith RNA extracts
from syngeneic and xenogeneic tumour-
immune lymphoid cells, particularly the
application to melanoma, Awhere again,
although the results are suggestive of benefit,
further trials are needed to resolve the prob-
lem. The effect of neuraminidase on cellular
immunity is covered in another chapter (17),
but greater emphlasis is put on the general
effects of immune responses in vivo and in
vitro rather than only the effect directly on
tumour-cell surfaces and in vivo behaviour of
enzyme-treated cells. Only a few chapters of
this book are devoted to treatment of specific
malignancies, and here too the background
immunology is stressed, rather than a review
of passed trials. With melanoma, evidence for
cellular and humoral responses is covered,
before a briefoutline ofimmunotherapy trials
covering BCG, immune RNA, levamisole,
etc. (Chapter 11). The whole ofChapter 12 is
devoted to the immunobiology of intra-
cranial tumours, before their attempted
immunotherapy is described in Chapter 13.
The earlier Chapter 4 similarly outlines the
evidence for the immunogenicity of human
breast cancer, based mainlv on the MTV
animal model, before describing briefly some
clinical trials. Three chapters (14-16) are
devoted to the possible non-specific adoptive
immunotherapy of cell leukaemia, basing
clinical potential on the results of work with
the AKR mouse leukaemia.
Clearly future immunotherapy must be
rational rather than empirical. This book
review,s some of these rational approaches for
future development, and indicates to the
reader where immunotherapy might be going,
rather than simply where it has been.
M. V. PIMM
Histological Typing ofUpper Respiratory
Tract Tumours (International Histo-
logical Classification of Tumours, No.
19). By K. SHANMUGARATNAM (1978).
Geneva: W.H.O. 56 pp. Sw.fr.285.
This volume in the WHO International
Histological Classification of Tumours covers
tumours of the ear, nose, nasopharynx and
larynx. It is likely to prove one of the most
valuable volumes in the series. Within the
anatomical regions surveyed, one may en-
counter tumours of the most varied histo-
genesis, in addition to tumours ofthe respira-
tory epithelia. Tumours of salivary, odonto-
genic, bony, neural and lymphoreticular
origin may all present as "ENT" problems,
and the pathologist -who has to reach a diag-
nosis on the often unsatisfactory specimens
provided by the ENT surgeon needs to be
familiar with all these tumours, and more
besides. He will find this volume an invaluable
guide. The definitions are crisp and dogmatic,
and the colour photographs are of excellent
quality and sho-w the essential features of
each lesion. The section on tumour-like
lesions is particularly valuable, as these often